Stock Events

CV Sciences 

$0.08
17
-$0-2.22% Friday 19:17

Statistics

Day High
0.09
Day Low
0.08
52W High
0.1
52W Low
0.03
Volume
108,500
Avg. Volume
397,669
Mkt Cap
16.07M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

14NovConfirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.08
-0.05
-0.03
-0
Expected EPS
-0.02
Actual EPS
-0.01

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CVSI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Process Industries
Consumer Services
Manufacturing
Other Consumer Services
Agricultural Commodities/Milling
All Other Miscellaneous Chemical Product and Preparation Manufacturing
CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense, and PlusCBD Pet brand names in various health care sectors, including nutraceutical, beauty care, specialty foods, and pet products. It sells its products through its websites, internet sales, elect distributors, brick and mortar retailers, and select e-tailers. The Specialty Pharmaceutical segment focuses on developing and commercializing cannabinoids to treat medical indications. This segment is developing drug candidate CVSI-007 that combines CBD and nicotine in treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
Show more...
CEO
Employees
42
Country
US
ISIN
US1266541028

Listings